Gainers

• Tenon Medical (NASDAQ:TNON) stock moved upwards by 76.4% to $4.3 during Thursday's regular session. The market value of their outstanding shares is at $1.6 million.
• AEON Biopharma (AMEX:AEON) shares increased by 35.08% to $0.31. The market value of their outstanding shares is at $11.5 million.
• Silexion Therapeutics (NASDAQ:SLXN) shares moved upwards by 24.86% to $0.44. The company's market cap stands at $1.9 million.
• BeyondSpring (NASDAQ:BYSI) shares rose 24.06% to $0.78. The company's market cap stands at $25.8 million.
• Indaptus Therapeutics (NASDAQ:INDP) shares rose 16.82% to $2.43. The market value of their outstanding shares is at $277.1 million.
• ZeroStack (NASDAQ:ZSTK) stock rose 14.59% to $4.85. The company's market cap stands at $10.2 million.

Losers

• CDT Equity (NASDAQ:CDT) shares decreased by 44.0% to $0.34 during Thursday's regular session. The market value of their outstanding shares is at $8.2 million.
• SL Science Holding (NASDAQ:SLBT) shares declined by 22.23% to $2.03. The company's market cap stands at $1.4 billion.
• Lexaria Bioscience (NASDAQ:LEXX) shares fell 16.37% to $5.52. The company's market cap stands at $13.9 million.
• BridgeBio Oncology (NASDAQ:BBOT) shares decreased by 16.36% to $5.65. The market value of their outstanding shares is at $541.5 million.
• Biohaven (NYSE:BHVN) stock fell 15.57% to $12.66. The market value of their outstanding shares is at $2.2 billion.
• Cooper Companies (NASDAQ:COO) shares decreased by 15.32% to $53.76. The market value of their outstanding shares is at $12.3 billion. As per the news, the Q3 earnings report came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.